[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

HbA1c Testing Market in India 2014

September 2014 | 132 pages | ID: HC42F157EABEN
Netscribes (India) Pvt. Ltd.

US$ 950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report is sent in 0-2 business days after order is placed.

Netscribes’ latest market research report titled HbA1c Testing Market in India 2014 states that with the increasing incidence of diabetes in the country, the demand for HbA1c testing is rising. India is characterized by the presence of a large diabetic population. The country’s status as the diabetes capital of the world has made the need for diabetes prevention and screening very important. Hence, tests for measuring the blood glucose levels are facing high demand within the country. Naturally, HbA1c testing in the country is also benefiting from this trend. The ability to measure one’s blood glucose levels over a period of 3 months has made it a test favored by many diabetics as well as people who believe they are at high risk of developing diabetes. The market for HbA1c testing has been growing steadily and with the awareness level regarding it increasing rapidly, the market is set to boom in the next few years.

Although the test is considered to be very useful for diabetes screening as well as for monitoring the diabetes status of a patient, its much higher cost compared to a simple blood sugar level test can act as a hindrance to its greater acceptance. However, the need to go for HbA1c tests only 3-4 times a year unlike the blood sugar level test which may have to be done on a monthly basis may work in favor of the former. Moreover, HbA1c tests give a clearer picture of the diabetes status of a patient as it a measurement of the glucose levels over a longer period. Several physicians also prescribe this test to their patients which in turn will increase its demand and thereby drive growth in the market.

Several large diagnostic chains offer these tests in India. Majority of the patients going for these tests are confirmed diabetics with very few non-diabetics undergoing this test. Most of the patients visiting laboratories for HbA1c tests have been prescribed to go for this test by a physician and very few people opt for the test on their own. However, with increasing awareness among people, this ratio is likely to change and many more people are expected to go for this test independently.
Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 – Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 – Jul 2013), Exchange Rate: Half Yearly (Oct 2013 – Mar 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Introduction
Slide 5: Healthcare Industry Overview, Healthcare Market Size & Growth (Value-Wise 2012 – 2018e), Healthcare Market –Segmentation (2012)
Slide 6: FDI Inflow in Indian Healthcare Segments
Slide 7: Healthcare Expenditure of Population by Economic Standard
Slide 8: Diabetes Prevalence Around the World
Slide 9: Diabetes – Global Overview, Global Prevalence of Diabetes (2011-2020e)
Slide 10: Region-Wise Diabetes Prevalence (2013), Region-Wise Undiagnosed Cases of Diabetes (2013)
Slide 11: HbA1c Testing – Overview

Market Overview
Slide 12: Diagnostic Service – Market Overview, Market Size & Growth (Value-Wise, 2012 – 2018e), Diagnostic Service Market-Split (2013), Diagnostic Service Market – Segmentation (2013)
Slide 13: Point-of-Care Testing – Market Overview, Market Size & Growth (Value-Wise, 2012 – 2018e)
Slide 14: SMBG – Market Overview, Market Size & Growth (Value-Wise, 2012 – 2018e)
Slide 15: HbA1c Tests – Market Overview, Market Size & Growth (Value-Wise 2012 to 2018e), HbA1c Tests Conducted Annually (2012 – 2017e)

Drivers & Challenges
Slide 16: Drivers & Challenges – Summary
Slide 17-21: Drivers
Slide 22-25: Challenges

Diabetes Disease Trends
Slide 26: Diabetes Disease Trends – Summary
Slide 27-33: Diabetes Related Diseases – Overview, Symptoms and Prevalence

Technology Trends
Slide 34-36: HbA1c Testing Methods
Slide 37: Comparative Study of the Prevalent HbA1c Testing Technologies
Slide 38: Major Players – High-performance Liquid Chromatography
Slide 39-40: HPLC Adoption by Different Hospitals and Diagnostic Centers
Slide 41: NGSP Certification – Overview & List of NGSP Certified Companies

Competitive Landscape
Slide 42: Porter’s Five Forces Analysis
Slide 43: Diagnostic Service Providers – Summary
Slide 44-47: Competitive Benchmarking – Diagnostic Service Providers
Slide 48-83: Major Diagnostic Service Players
Slide 84: HbA1c Analyzer and Reagent Manufacturers – Summary
Slide 85-87: Competitive Benchmarking – HbA1c Analyzer and Reagent Manufacturers
Slide 88-129: Major HbA1c Analyzer and Reagent Players

Strategic Recommendations
Slide 130: Strategic Insights

Appendix
Slide 131: Key Ratios Description
Slide 132: Sources of Information

Healthcare Industry Overview:

  • Favorable demographics, increase in awareness levelsand better medical care are some factors that aredriving the healthcare sector in India.
  • Segment 1 comprise the largest segment of overallhealthcare market, followed by pharmacy, medicalequipment, diagnostics and healthcare IT.
  • Gradual penetration of health insurance is stepping upaffordability of health services through increaseddemand for preventive and curative healthcare services.
  • Superior quality healthcare, coupled with low treatment costs in comparison to other countries, is benefitting Indian medical tourism, thereby driving theIndian healthcare market.
  • Treatment for major surgeries in India costs approximately 20% of that in developed countries.

Diagnostic Service – Market Overview:

  • Enhanced physician knowledge, coupled with bettertechnology in the field of diagnostics, is causing theIndian market to grow
  • Rise in lifestyle diseases has caused medical diagnosticsmarket to grow immensely in tier II and tier III cities
  • Diagnostic market is characterized by the presence oflarge number of labs in the unorganized sector that arenot accredited

HbA1c –Market Overview:

  • HbA1c tests can be offered exclusively or in packages with other tests by the diagnostic service providersHbA1c –Market Overview
  • Technology ‘A’ is currently the most common method adopted for conducting HbA1c tests in India•PoCT for HbA1c testing at the household level is not available in the domestic market and hence, the laboratories andhospitals offering HbA1c tests hold 100% market share
  • here is a growing level of awareness among the diabetic patient population of India about HbA1c testing which isleading them to take the test independently which in turn will suitably drive the HbA1c testing market in India


More Publications